Anemia management: development of a rapidaccess anemia and intravenous iron service.
This article describes the initiation and evolution of the Rapid-Access Anemia Clinic (RAAC) at Guy's and St Thomas' Hospitals, London, UK. This clinic was set up to provide diagnosis and treatment, and to coordinate investigative procedures, where necessary, into the underlying causes of anemia. Initially piloted with anemic preoperative orthopedic patients, the clinic now treats a wide range of conditions, deriving from both internal and external referrals. Treatment includes dietary advice, supplementation with iron, vitamin B12 and folate, and blood transfusion. Most patients at the RAAC need iron replacement, the majority of which require intravenous (IV) iron. Therefore the first-line IV iron-administration protocol is carefully considered to ensure viability of the service and patient satisfaction. Four IV irons available in the UK are discussed, with explanation of the benefits and drawbacks of each product and the reasoning behind the IV iron choice at different stages of the RAAC's development. Costs to the service, affected by IV iron price and administration regimen, are considered, as well as the product's contraindications. Finally, the authors reflect on the success of the RAAC and how it has improved patients' quality-of-treatment experience, in addition to benefiting the hospital and National Health Service in achieving specific health-care mandates and directives. Drawing from the authors' experiences, recommendations are given to assist others in setting up and providing a successful rapid-access anemia service or similar facility.
Haematology Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Deepti
D
Radia
Ibrahim
I
Momoh
Richard
R
Dillon
Yvonne
Y
Francis
Laura
L
Cameron
Toni-Lee
TL
Fagg
Hannah
H
Overland
Susan
S
Robinson
Claire N
CN
Harrison
ferric carboxymaltose; hemoglobin; iron deficiency; iron dextran; iron isomaltoside; iron sucrose